Results 111 to 120 of about 3,715,425 (177)

Efficacy and safety of GLP-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized clinical trials. [PDF]

Neurol Sci
Mendonça MF, Interaminense AC, do R Barros GST, Rabelo LA, de Oliveira PG, Sales RF, de C Lyra AMV, de S E Silva HR.   +7 more
europepmc   +1 more source

Investigation of lung transplant recipients' medical treatment compliance and gastrointestinal symptoms in the long term: A cross-sectional study. [PDF]

Medicine (Baltimore)
Vural A, Bulbuloglu S, Sevin R.
europepmc   +1 more source

Demographics, treatment patterns, and healthcare resource utilization in Parkinson's disease: a real-world data study using a claims database. [PDF]

Arq Neuropsiquiatr
Chehin AB, Abrahão LR, Fuga MAM, Almeida ABM, Santos ACD, Parmera JB.   +5 more
europepmc   +1 more source

The "Wearing Off" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease. [PDF]

HCA Healthc J Med
Cromwell R, Um T.
europepmc   +1 more source

[Abuse of the antiparkinson agents biperidin and benzhexol].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983
openaire   +1 more source

Carotenoids as Antiparkinson Agents

, 2021
Parkinson’s disease (PD) is a neurodegenerative disease associated with the loss of dopaminergic neurons in the portions of the brain via multiple pathological mechanisms. Despite the fact that enormous progress occurred in the cure of Parkinson’s disorder, but the incidence and risk of this disease is increasing alarmingly over the past few decades ...
Saikat Dewanjee, Muhammad Zia-Ul-Haq, Muhammad Riaz, Shounak Sarkhel, Pratik Chakraborty, Sagheer Ahmed   +5 more
semanticscholar   +3 more sources

Exploiting second-order advantage from mathematically modeled voltammetric data for simultaneous determination of multiple antiparkinson agents in the presence of uncalibrated interference [PDF]

Journal of the Taiwan Institute of Chemical Engineers, 2018
In this work, we are going to develop an efficient electroanalytical methodology based on generation of second-order differential pulse voltammetric (DPV) data at different pulse heights to exploit second-order advantage for simultaneous determination of
Ghobad Mohammadi, Khodabakhsh Rashidi, Hector C Goicoechea   +2 more
exaly   +3 more sources

New L‐Dopa Codrugs as Potential Antiparkinson Agents

Archiv der Pharmazie, 2008
AbstractThis paper reports the synthesis and preliminary evaluation of newL‐dopa (LD) conjugates (1and2) obtained by joining LD with two different natural antioxidants, caffeic acid and carnosine, respectively. The antioxidant efficacy of compounds1and2was assessed by evaluating plasmatic activities of superoxide dismutase (SOD) and glutathione ...
SOZIO, Piera, IANNITELLI, ANTONIO, CERASA LS, CACCIATORE, Ivana, CORNACCHIA, CATIA, GIORGIONI G, RICCIUTELLI M, NASUTI C, CANTALAMESSA F, DI STEFANO, Antonio   +9 more
semanticscholar   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms

American Journal of Health-System Pharmacy, 1979
The types of extrapyramidal syndrome (EPS) reactions produced by antipsychotic agents and the prophylactic use of antiparkinson agents in preventing EPS are reviewed. EPS are classified as akathisias, dystonias, parkinson-like symptoms and tardive dyskinesia, and have a varied incidence reported to range from 10.6 to 100%.
John E Murphy, Ronald B Stewart, Murphy John E   +2 more
exaly   +4 more sources

Some New Piperazino Derivatives as Antiparkinson and Anticonvulsant Agents

Archiv Der Pharmazie, 1983
AbstractThe piperazino derivatives 1–7 were synthesized and evaluated for their antiparkinson activity on oxotremorine‐induced tremors and reserpine‐induced rigidity. The same compounds were screened for their anticonvulsant activity. Compounds 1, 3, 4 and 5 showed promising antiparkinson activity.
G P Gupta, Krishna P Bhargava, K Shanker   +2 more
exaly   +4 more sources